GAPDHP65: Potential Drug Target Or Biomarker (G389849)

Target Name: GAPDHP65

NCBI ID: G389849

GAPDHP65

Other Name(s): glyceraldehyde 3 phosphate dehydrogenase pseudogene 65 | Glyceraldehyde 3 phosphate dehydrogenase pseudogene 65 | GAPDHL10 | GAPDL10

GAPDHP65: Potential Drug Target Or Biomarker

GAPDHP65 (Glyceraldehyde 3-Phosphate Dehydrogenase Pseudogene 65) is a gene that encodes a protein known as GAPDHP65 in humans. The protein is a key enzyme in the pathway of cellular energy metabolism, which is involved in the production of ATP, a vital energy compound that is used by the cell to perform various physiological functions.

GAPDHP65 is a pseudogene, which means that it is a genetic variation in the gene that has not been expressed in the cell. However, the pseudogene has been shown to encode a functional protein that is involved in a wide range of cellular processes, including metabolism, inflammation, and development.

One of the interesting aspects of GAPDHP65 is its potential as a drug target or biomarker. The GAPDHP65 enzyme has been shown to play a key role in the production of reactive oxygen species (ROS), which can cause damage to cells and contribute to a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

In addition, GAPDHP65 has also been shown to be involved in the regulation of cellular signaling pathways, which can affect a wide range of cellular processes, including cell growth, differentiation, and inflammation. This suggests that GAPDHP65 may be a useful target for the development of new drugs or therapies aimed at treating these diseases.

GAPDHP65 has also been shown to be involved in the production of various signaling molecules, including activating transcription factor-3 (ATF-3), which plays a key role in the regulation of cellular growth and differentiation. This suggests that GAPDHP65 may be a useful target for the development of drugs that promote cellular growth and differentiation, such as those used to treat cancer.

Another potential application of GAPDHP65 is its role in the regulation of inflammation. The GAPDHP65 enzyme has been shown to play a key role in the production of pro-inflammatory cytokines, which contribute to the inflammatory response that occurs in response to various stimuli. This suggests that GAPDHP65 may be a useful target for the development of drugs aimed at treating inflammatory disorders.

In conclusion, GAPDHP65 is a gene that encodes a protein that is involved in a wide range of cellular processes, including energy metabolism, signaling pathways, and inflammation. Its potential as a drug target or biomarker makes it an attractive target for the development of new therapies aimed at treating various diseases. Further research is needed to fully understand the role of GAPDHP65 in cellular processes and its potential as a drug.

Protein Name: Glyceraldehyde 3 Phosphate Dehydrogenase Pseudogene 65

The "GAPDHP65 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GAPDHP65 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets